LXH254 - Naporafenib

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 3556

CAS [1800398-38-2]

MF C25H25F3N4O4
MW 502.49

  • Purity: 99%
  • Soluble in DMSO and EtOH
Recently added

LXH254

Description

LXH254 is a potent, selective, orally available and ARAF-sparing type II inhibitor of BRAF and CRAF with IC50 values of 0.21 and 0.072 mM for BRAF and CRAF, respectively.

KEYWORDS: LXH254 | Supplier | B/C RAF inhibitor | Naporafenib | LXH 254 | LXH-254 | CAS [1800398-38-2] | MEK | RAF | Inhibitor | Enzymes | RAS mutant tumor | BRAFV600mut melanoma | MAPK-driven tumor

Order
Size Unit Price Stock
5 mg €180.00 In Stock
25 mg €580.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €280.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...